Anavex Life Sciences Corp (AVXL)

[McMagyar]

I would think the fact that we KNOW, from preliminary data ALREADY RELEASED, that almost 80% of Patients (11 of 14) at 12 WEEKS showed the greatest response ever seen(this is not necessarily a factual statement, but I have not found any drug that had a better response at 12 WEEKS in previous testing), +3.21 on an ADAS-??? Scale at 12 Weeks..
Why are we regressing to a computer model when we have actual human data in hand? so let's extrapolate from the preliminary 12 WEEK data set, say 23 out of 30 Patients show a similar marked improvement at 12 weeks and then maintain that improvement over 26 weeks..that could be 1/2 a year of independent living..birthdays remembered, stories told, golf played, tea drank with the proper ingredients. names remembered..6 months is forever! As long as the safety profile continues to show minimal risk and only short term minimal discomfort, A2-73 has already shown more efficacy than anything that has ever been tried! And through BIOMARKER Improvement and the nature of A2-73 being preventive, the SOONER people start protecting their brains with A2-73 .perhaps,the better..This is why I think Anavex will release 12/26 WEEK Part B data at the BIOMARKER'S Conference in San Diego, March 22(?)..